Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Patient Navigation × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 20 Breast 12 Thoracic 9 Gynecologic 7 Tumor-Agnostic 5 Other hematologic neoplasm 3 Lymphoid 3 Genitourinary 2 Plasma cell 1 Other solid neoplasm 1 Other 1 Head & Neck 1 Endocrine 1

Conditions

Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 541 pembrolizumab 283 Radiotherapy 279 Cetuximab 235 Docetaxel 196 Radiotherapy, Intensity-Modulated 186 Fluorouracil 174 Carboplatin 173 Paclitaxel 146 Nivolumab 120 Gemcitabine 112 Radiation 76 Magnetic Resonance Spectroscopy 76 toripalimab 68 Drug Therapy 68 Capecitabine 67 durvalumab 54 Surgical Procedures, Operative 53 Biopsy 48 Cyclophosphamide 43 camrelizumab 41 Standard of Care 39 Chemoradiotherapy 39 Specimen Handling 38 Erlotinib Hydrochloride 38 Bevacizumab 38 tislelizumab 37 130-nm albumin-bound paclitaxel 36 Radiosurgery 35 atezolizumab 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03821064 2021-02-01

NDURE

Medical University of South Carolina

Phase NA Completed

11 enrolled 28 charts

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡